Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study

Title: Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study
Authors: Taylor, Carolyn; McGale, Paul; Probert, Jake; Broggio, John; Charman, Jackie; Darby, Sarah C; Kerr, Amanda J; Whelan, Timothy; Cutter, David J; Mannu, Gurdeep; Dodwell, David
Publisher Information: BMJ Publishing Group Ltd
Publication Year: 2023
Collection: HighWire Press (Stanford University)
Subject Terms: RESEARCH
Description: Objectives To describe long term breast cancer mortality among women with a diagnosis of breast cancer in the past and estimate absolute breast cancer mortality risks for groups of patients with a recent diagnosis. Design Population based observational cohort study. Setting Routinely collected data from the National Cancer Registration and Analysis Service. Participants All 512 447 women registered with early invasive breast cancer (involving only breast and possibly axillary nodes) in England during January 1993 to December 2015, with follow-up to December 2020. Main outcome measures Annual breast cancer mortality rates and cumulative risks by time since diagnosis, calendar period of diagnosis, and nine characteristics of patients and tumours. Results For women with a diagnosis made within each of the calendar periods 1993-99, 2000-04, 2005-09, and 2010-15, the crude annual breast cancer mortality rate was highest during the five years after diagnosis and then declined. For any given time since diagnosis, crude annual breast cancer mortality rates and risks decreased with increasing calendar period. Crude five year breast cancer mortality risk was 14.4% (95% confidence interval 14.2% to 14.6%) for women with a diagnosis made during 1993-99 and 4.9% (4.8% to 5.0%) for women with a diagnosis made during 2010-15. Adjusted annual breast cancer mortality rates also decreased with increasing calendar period in nearly every patient group, by a factor of about three in oestrogen receptor positive disease and about two in oestrogen receptor negative disease. Considering just the women with a diagnosis made during 2010-15, cumulative five year breast cancer mortality risk varied substantially between women with different characteristics: it was
Document Type: text
File Description: text/html
Language: English
Relation: http://www.bmj.com/cgi/content/short/381/jun13_1/e074684; http://dx.doi.org/10.1136/bmj-2022-074684
DOI: 10.1136/bmj-2022-074684
Availability: http://www.bmj.com/cgi/content/short/381/jun13_1/e074684; https://doi.org/10.1136/bmj-2022-074684
Rights: Copyright (C) 2023, BMJ Publishing Group Ltd
Accession Number: edsbas.BBAE1853
Database: BASE